Agenus, Inc. (AGEN): Total Asset Value of Company
Agenus (AGEN) is competing in the immunotherapy sector by developing next-generation antibodies and seeking alliances to shield itself from pricing pressure. The business is based on the treatment of colorectal cancer, where high patient survival rates have become a competitive advantage. This chart of price changes for total assets, valued at 178.53, reflects the company's dynamics. A unique development portfolio allows Agenus (AGEN) to dictate licensing terms when partnering with industry behemoths.
Comprehensive metric breakdowns and analytics for Agenus Inc (AGEN)
- price and consensus price forecast:
- market capitalization data:
- book capitalization data:
- debt and liquidity data:
Fundamental valuation:AGEN, agenusbio.com
Fundamental screening of defensive assets requires a precise definition of the issuer's material base. Total assets, calculated inversely via ROA, combine equity and liabilities to assess real resource potential. For Agenus (AGEN), this metric confirms sustainable development within an independent cycle of medical innovation. The dynamics of controlled resource values allow for an objective assessment of the company's financial stability, eliminating market distortions.
Competitors of Agenus (AGEN)
ARGX (argenx.com) - Total Business Assets|Aggregate Company Assets BioNTech BNTX|Total Asset Value of Company Abivax|ADMA Bio (ADMA) - Company Total Assets|Aggregate Asset Value Protagonist Corp (PTGX)|Company Total Assets IMVT (Immunovant, Inc.)|kiniksa.com - Company Total Assets|Aggregate Company Assets Grifols (GRFS)|ADPT: Aggregate Asset Value|CLDX (Celldex) - Aggregate Company Assets|Aurinia Corp (AUPH) - Cumulative Company Assets|BCRX (BioCryst) - Company Total Assets|Company Total Assets veratx.com (VERA)|Dianthus Therapeutics, Inc. (DNTH) - Cumulative Company Assets|Aggregate Asset Value Pharvaris NV (PHVS)|Company Total Assets ABCL|Tourmaline - Company Total Asset Base|PGEN: Aggregate Company Assets|PHAR: Cumulative Company Assets|NKTR (Nektar Therapeutics Inc.) - Aggregate Company Assets|Cumulative Company Assets Upstream Bio, Inc.|ZBIO (Zenas Biopharma, Inc.) - Cumulative Company Assets|Company Total Assets IMNM|Aggregate Company Assets Gossamer Bio, Inc. GOSS|Total Business Assets kalvista.com (KALV)|SEPN: Company Total Assets|Company Assets Pieris Pharma PVLA|Savara Corp - Company Total Assets|RIGL - Company Total Assets|Company Total Assets ANAB (AnaptysBio, Inc.)|astriatx.com (ATXS) - Company Balance Sheet Assets|Company Total Assets ENGN (enGene)|Company Assets RAPT|Aggregate Company Assets Aerovate Therapeutics Inc JBIO|Total Business Assets Aclaris Therapeutics, Inc ACRS|Cumulative Company Assets KYTX (Kyverna Therapeutics)|tizianalifesciences.com - Company Total Assets|Aggregate Company Assets CABA (Cabaletta Bio)|VTYX - Company Total Asset Base|THTX: Company Total Assets|Avalo Therapeutics Inc (AVTX) - Company Total Assets|Eledon Pharmaceuticals - Company Total Assets|Company Balance Sheet Assets climbbio.com|Zura Bio - Company Total Assets|Company Assets ATYR (aTyr Pharma Inc)|ADAG - Aggregate Company Assets|ImageneBio - Total Business Assets|Aggregate Company Assets Shattuck Therapeutics|EQ - Total Asset Value of Company|Company Total Assets connectbiopharm.com CNTB|Immunic (IMUX) - Aggregate Asset Value|ATRA (Atara Biotherapeutics, Inc.) - Company Total Assets|Company Total Assets IFRX|X4 Pharmaceuticals (XFOR) - Aggregate Company Assets|Aggregate Asset Value ACET (adicetbio.com)|Celularity - Aggregate Company Assets|Cumulative Company Assets INmune Bio Inc INMB|Barinthus Bio - Company Total Assets|Kezar Life Sciences Inc (KZR) - Company Total Assets|Cumulative Company Assets SAB Biotherapeutics SABS|akaritx.com (AKTX) - Aggregate Asset Value|ENLV: Company Total Assets|Company Total Asset Base QTTB|Aggregate Company Assets GOVX (GeoVax Labs Inc)|Cumulative Company Assets EDSA (Edesa Biotech Corp)|iBio, Inc. - Aggregate Company Assets|CARM - Cumulative Company Assets|XTL Biopharmaceuticals Ltd. - Cumulative Company Assets|BOLT: Company Total Assets|Aggregate Company Assets hcwbiologics.com|Aptevo Therapeutics Inc. (APVO) - Total Business Assets|Company Total Assets AIM (AIM ImmunoTech Inc.)|Company Assets Aditxt Corp|Company Total Assets GRI|Company Total Assets XORTX Therapeutics Inc (XRTX)|HIND (ReShape Lifesciences) - Company Total Assets|Company Balance Sheet Assets Revelation Biosciences Corp REVB|INDP (Indaptus Therapeutics) - Company Total Assets|SCNI: Company Assets|Aggregate Company Assets calcimedica.com|Total Business Assets Affimed N.V.|ALLK (Allakos Inc) - Cumulative Company Assets|Company Total Assets HOOK|IGMS (IGM Biosciences, Inc.) - Aggregate Company Assets|Company Total Asset Base iteostherapeutics.com (ITOS)|Company Total Assets OCEA (Ocean Biomedical)|Company Total Assets TC BioPharm (Holdings) Plc TCBP|Company Total Assets THRD